Sanofi Pasteur ships influenza virus vaccine to US
The shipment represents more than 60 million doses of seasonal influenza vaccine the company plans to deliver to health care providers in the US this influenza season. Sanofi
The US Food and Drug Administration (FDA) has approved AstraZeneca’s Imfinzi (durvalumab) in combination with Padcev (enfortumab vedotin) for adult patients with muscle-invasive bladder cancer (MIBC) who cannot receive or have refused cisplatin-based chemotherapy.